Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30

$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Luxembourg EUR Issuing Entity by Quarter

Name: Novartis Luxembourg EUR Issuing Entity by Quarter (NVS)
Creator: Novartis

Luxembourg EUR Issuing Entity — Novartis Finance S.A. (8 Bond Issues) ($M)

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

Period	Ended	Luxembourg EUR Issuing Entity — Novartis Finance S.A. (8 Bond Issues) ($M)	Year on year	Source

Breakdown

What makes up luxembourg EUR Issuing Entity

EUR 1850M Bond (0.0001%, 2020–2028)–
EUR 500M Bond (0.625%, 2016–2028)–
EUR 600M Bond (1.125%, 2017–2027)–
EUR 750M Bond (1.375%, 2018–2030)–
EUR 600M Bond (1.625%, 2014–2026)–
EUR 750M Bond (1.700%, 2018–2038)–

Cite this data

StockData. (2026). Novartis Luxembourg EUR Issuing Entity ($M), quarterly [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/sub-issuer-nfsa-lux

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.